Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection

Neurology

Volumn 48, Issue 3, 1997, Pages 717-724

  Ho, T W ^a,f   Hsieh, S T ^a   Nachamkin, I ^e   Willison, H J ^c   Sheikh, K ^a   Kiehlbauch, J ^b   Flanigan, K ^a   McArthur, J C ^a   Cornblath, D R ^a   McKhann, G M ^d   Griffin, J W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WADSWORTH CENTER   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CAMPYLOBACTER; CASE REPORT; DIARRHEA; FEMALE; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; MOTOR NEUROPATHY; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; NERVE DEGENERATION; NERVE ENDING; PARALYSIS; PRIORITY JOURNAL; RANVIER NODE;

EID: 0030943761     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.3.717     Document Type: Article

References (56)

1. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Medicine 1969;48:173-215.
2. Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978;3: 565-566.
3. Prineas JW. Acute idiopathic polyneuritis: an electron microscope study. Lab Invest 1972;26:133-147.
4. Feasby TE, Hahn AF, Brown WF, Bolton CF, Gilbert JJ, Koopman WJ. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J Neurol Sci 1993;116:185-192.
5. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-1126.
6. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China: The spectrum of neuropathologic changes in clinically defined cases. Brain 1995;118:577-595.
7. Griffin JW, Li CY, Macko C, et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol 1996;25:33-51.
8. Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996;39: 17-28.
9. Hafer-Macko C, Hsieh S-T, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996;40:635-644.
10. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342.
11. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
12. Hafer-Macko C, Sheikh KA, Li CY, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996;39:625-635.
13. Walsh FS, Cronin M, Koblar S, et al. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol 1991; 34:43-51.
14. Fujimoto S, Yuki N, Itoh T, Amako K. Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome [letter]. J Infect Dis 1992;165:183.
15. Yuki N, Sato S, Fujimoto S, Yamada Y, Kinoshita A, Itoh T. Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome. Muscle Nerve 1992;16:968-969.
16. Yuki N, Handa S, Taki T, Kasama T, Takahashi M, Saito K. Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barré syndrome: molecular mimicry between gangliocide GM1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomed Res 1992;13: 451-453.
17. Willison HJ, Paterson G, Kennedy PG, Veitch J. Cloning of human anti-GM1 antibodies from motor neuropathy patients. Ann Neurol 1994;35:471-478.
18. Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-816.
19. Rees JH, Gregson NA, Soudain SE, Hughes RAC. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-1379.
20. Kusunoki S, Chiba A, Kon K, et al. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol 1994;35:570-576.
21. Kornberg AJ, Pestronk A, Bieser K, et al. The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann Neurol 1994; 35:234-237.
22. Gregson NA, Jones D, Thomas PK, Willison HJ. Acute motor neuropathy with antibodies to GM1 ganglioside. J Neurol 1991;238:447-451.
23. Wirguin I, Suturkova-Milosevic L, Della-Latta P, Fisher T, Brown RH Jr, Latov N. Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides. Ann Neurol 1994; 35:698-703.
24. Ho TW, Li CY, Cornblath DR, Gao CY, Asbury AK, Griffin JW, McKhann GM. Patterns of recovery in the Guillain-Barré syndromes. Neurology 1997;48:695-700.
25. + currents in isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436-442.
26. Roberts M, Willison H, Vincent A, Newsom-Davis J. Guillain-Barré syndrome and neurotransmitter release [abstract]. Lancet 1994;343:454-455.
27. Uncini A, Santoro M, Corbo M, Lugaresi A, Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 1993;16:610-615.
28. Thomas FP, Trojaborg W, Nagy C, et al. Experimental autoimmune neuropathy in rabbits immunized with Gal-(beta1-3)Gal NAc or GM1, with partial conduction block and IgG and IgM deposits at nodes of Ranvier [abstract]. J Neurol Sci 1990;98(suppl):69.
29. Santoro M, Uncini A, Corbo M, et al. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 1992;31:385-390.
30. Roberts M, Willison H, Vincent A, Newsom-Davis J. Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet 1994;343:454-455.
31. Nachamkin I. Campylobacter and Arcobacter. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: ASM Press, 1995:483-491.
32. Kiehlbauch JA, Cameron DN, Wachsmuth IK. Evaluation of ribotyping techniques as applied to Arcobacter, Campylobacter, Helicobacter and related species. Mol Cell Probes 1994;8:109-116.
33. Kiehlbauch JA, Plikaytis BD, Swaminathan B, Cameron DN, Wachsmuth IK. Restriction fragment length polymorphisms in the ribosomal genes for the species identification and subtyping of aerotolerant Campylobacter species. J Clin Microbiol 1991;29:1670-1676.
34. Nachamkin I, Bohachick K, Patton CM. Flagellin gene typing of Campylobacter jejuni by restriction fragment length polymorphism analysis. J Clin Microbiol 1993;31:1531-1536.
35. Nachamkin I, Ung H, Patton CM. Analysis of HL and O serotypes of Campylobacter by the flagellin gene typing system. J Clin Microbiol 1996;34:277-281.
36. Penner JL, Hennessy JN. Passive hemagglutination techniques for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J Clin Microbiol 1980;12: 732-737.
37. Westphal O, Jann K. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. Methods Carbohdr Chem 1965;5:83-91.
38. Tsai CM, Frasch CE. A sensitive silver stain for detecting LPS in polyacrylamide gels. Anal Biochem 1982;119:115-119.
39. Crawford TO, Hsieh S-T, Schryer BL, Glass JD. Prolonged axonal survival in transected nerves of C57BL/Ola mice is independent of age. J Neurocytol 1995;24:333-340.
40. McCarthy BG, Hsieh S-T, Stocks EA, et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995;45:1848-1855.
41. Patton CM, Shaffer N, Edmonds P, et al. Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States. J Clin Microbiol 1989;27:66-73.
42. Mishu B, Ilyas AA, Koski CL, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med 1993;118:947-953.
43. Preston MA, Penner JL. Structural and antigenic properties of lipopolysaccharides from serotype reference strains of Campylobacter jejuni. Infect Immun 1987;55:1806-1812.
44. Ropper AH. Severe acute Guillain-Barré syndrome. Neurology 1986;36:429-432.
45. Chaudhry V, Cornblath DR. Wallerian degeneration in human nerves: serial electrophysiological studies. Muscle Nerve 1992;15:687-693.
46. Cros D, Triggs WJ. There are no neurophysiologic features characteristic of "axonal" Guillain-Barré syndrome. Muscle Nerve 1994;17:675-677.
47. Haymaker W, Kernohan JW. The Landry-Guillain-Barré syndrome: a clinicopathologic report of fifty fatal cases and a critique of the literature. Medicine 1949;28:59-141.
48. Griffin JW, Cornblath DR, Ho TW, McKhann GM, Asbury AK, Li CY. Guillain-Barré syndrome in northern China: The spectrum of neuropathological changes in clinically defined cases [letter]. Brain 1996;119:675-680.
49. Ganser AL, Kirschner DA. Differential expression of gangliosides on the surfaces of myelinated nerve fibers. J Neurosci Res 1984;12:245-255.
50. Corbo M, Quattrini A, Latov N, Hays AP. Localization of GM1and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 1993;43:809-814.
51. Apostolski S, Sadiq SA, Hays A, et al. Identification of Gal(beta1-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J Neurosci Res 1994;38:134-141.
52. Illa I, Ortiz N, Gallard E, Juarez C, Grau JM, Dalakas MC. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol 1995;38:218-224.
53. Goossens H, Vlaes L, DeBoeck M, et al. Is "Campylobacter upsaliensis" an unrecognized cause of human diarrhea? Lancet 1990;335:584-586.
54. Lastovica AJ, Le Roux E, Penner JL. "Campylobacter upsaliensis" isolated from blood cultures of pediatric patients. J Clin Microbiol 1989;27:657-659.
55. Taylor DN, Perlman DM, Echeverria PD, Lexemboon U, Blaser MJ. Campylobacter jejuni and quantitative excretion rate in Thai children. J Infect Dis 1993;168:745-758.
56. 1a antibodies. Muscle Nerve 1992;15:899-903.